Future Medicine Science Match 2020
ARTIFICIAL INTELLIGENCE IN TRANSLATIONAL MEDICINE
7 November 2020 *** This Year As Digital Edition ***
In recent years, the Futue Medicine Science Match has become one of the most exciting annual events in terms of medical innovations and visions for the future of translational medicine. In 2020, for the fifth time now, the Berlin Institute of Health and the publishing house Der Tagesspiegel will continue this story, together with Charité – Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC).
Each year, 800 guests or more attended the talks of 60 to 80 rising stars of science from innovative research institutions in Berlin, Germany, and the world. Only in one day, the speakers presented cutting-edge projects in the area of Digital Health and Translational Medicine, showing how their work will turn advances in life science research into benefits for patients and people.
This year we aim at highlighting the advancements in the field of artificial intelligence in translational medicine.
The three key topics of Future Medicine Science Match 2020 on 7 November will be:
- AI and Basic Medical Research
- AI and Decision Making in Medicine
- AI and SARS-CoV-2/COVID-19
The core of our Science Matches is a series of fast-paced 3-minute short talks. Top scientists from leading Berlin institutions and international partners will present their pioneering work and how it will change the future of medicine.
Because of the Corona Pandemic, we will hold the Science Match as a digital event this year and are truly looking forward to the new virtual setting and to an extended outreach. There will be a livestream, where pitches alternate with keynote, interview and debate, and an event website, where pre-produced pitches and other content can be accessed before, during and after the livestream. Participant action and interaction plays a major role, so there will be opportunities to comment, vote, ask questions, discuss and network.
We look forward to your participation!
Scientific Program Committee
Prof. Petra Ritter
BIH Johanna Quandt Professor for Brain Simulation
Berlin Institute of Health (BIH) and Charité – Universitätsmedizin Berlin
Session Chair for AI and Decision Making in Medicine
Dr. Roland Schwarz
Group Leader Evolutionary and Cancer Genomics
Berlin Institute for Medical Systems Biology (BIMSB), Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)
Session Chair for AI and Basic Medical Research
Prof. Sylvia Thun
Director Core Unit eHealth and Interoperability (CEI)
Berlin Institute of Health (BIH) and Charité – Universitätsmedizin Berlin
Scientific Director of Future Medicine 2020 and Session Chair for AI and SARS-CoV-2/COVID-19
If you are interested in AI topics beyond Future Medicine 2020, please feel free to browse the links below to our thematically related podcasts and press releases.
Podcasts about the use of artificial intelligence in translational medicine
Can an app help with intimate problems?
Artificial Intelligence disadvantages female patients?
How can the computer help to better understand the brain?
Press releases about the use of artificial intelligence in translational medicine
AI in the fight against cavities: BIH Digital Health Accelerator supports spin-off of the start-up dentalXrai
Together with data scientists and programmers, dentists at the Charité – Universitätsmedizin Berlin developed the software dentalXrai Pro, which allows dental practitioners to perform AI-based analysis of X-ray images. Since 2017, the team has been working with a clear goal in mind: to help dentists identify pathologies and restorations more accurately and in less time on X-rays of the jaw, enabling optimal treatment and improved patient communication. The Digital Health Accelerator of the Berlin Institute of Health (BIH) assisted and financed the project from prototype and product development all the way to the spin-off of the start-up dentalXrai GmbH.
Precise diagnostics with AI: BIH Digital Health Accelerator guides Aignostics GmbH through its spin-off
The usual way to determine if a suspicious lump is cancerous involves microscopic examination in a pathology laboratory. To ease the workload of pathologists who face a rising number of cancer cases and increasingly finer molecular details and to enable tailored treatments, scientists at the Institute of Pathology of Charité – Universitätsmedizin Berlin have teamed up with colleagues at TU Berlin to develop a digital imaging analysis system that uses artificial intelligence (AI) to evaluate microscopic images. The Digital Health Accelerator (DHA) of the Berlin Institute of Health (BIH) is helping the scientists to make the long-term research project a translational success. The DHA is a support and development program of BIH Innovations, the joint technology transfer unit of the BIH and Charité.
Artificial intelligence for detecting strokes during sleep
At the seventh research idea competition “Forum Junge Spitzenforscher,” organized by Stiftung Industrieforschung and Humboldt-Innovation, the team of Dr. Ludwig Schlemm, a neurology specialist and research assistant at the Department of Neurology of Charité – Universitätsmedizin Berlin and a participant in the BIH Charité Clinician Scientist Program, took first place. The team is planning the development of an AI-based method for the early detection of strokes during sleep. The competition is geared toward outstanding young researchers in Berlin whose practice-oriented AI ideas emerge from their innovative basic research. The award comes with prize money of €10,000.